A recent study found that switching from entecavir (ETV) to tenofovir alafenamide (TAF) in chronic hepatitis B patients showed similar effects on serum HBsAg levels over 240 weeks.
A clinical trial is underway at West China Hospital of Sichuan University to assess the efficacy of nucleos(t)ide analogs (NAs) in patients with positive hepatitis B virus (HBV) DNA.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.